Clinical Trial Update: Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety, tolerability, and efficacy of Evenamide for chronic schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Evenamide (Evenamide)

Snippet

Sponsor: Newron Pharmaceuticals SPA | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED